34 results
6-K/A
NYMXF
Nymox Pharmaceutical Corp
16 Nov 22
Current report (foreign) (amended)
12:23pm
, the Corporation’s intention is to provide a direct link between corporate performance and executive compensation while maximizing shareholder value
6-K
NYMXF
Nymox Pharmaceutical Corp
10 Nov 22
Current report (foreign)
6:24pm
, the Corporation’s intention is to provide a direct link between corporate performance and executive compensation while maximizing shareholder value
6-K/A
EX-99.2
NYMXF
Nymox Pharmaceutical Corp
22 Nov 21
Notice of the Annual General Meeting of the Shareholders
1:31pm
and executive compensation while maximizing shareholder value and controlling cash expenditures.
Summary Compensation Table: Named Executive Officers
Non
6-K
EX-99.2
zm5uk ogb9mb17s1
19 Nov 21
Notice of the Annual General Meeting of the Shareholders
4:36pm
6-K
EX-99.2
81su4l9e83em
20 Nov 20
Notice of the Annual General Meeting of the Shareholders
1:13pm
6-K
EX-99.2
phtjw5r 1w6oximaa
19 Nov 19
Notice of the Annual General Meeting of the Shareholders
2:55pm
6-K
EX-99.2
yra4b5w886eftra
23 Nov 18
Notice of the Annual General Meeting of the Shareholders
7:28pm
20-F/A
ifzg99ci2ibyoj22v
11 May 18
Annual report (foreign) (amended)
4:22pm
6-K
EX-99.1
v2jvb868qng3g
21 Apr 14
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K/A
EX-99.2
pv99j6
21 Apr 14
Report of Foreign Issuer for the Month of April 2014
12:00am